Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1991 Jul;46(7):499–503. doi: 10.1136/thx.46.7.499

Budesonide and terbutaline or terbutaline alone in children with mild asthma: effects on bronchial hyperresponsiveness and diurnal variation in peak flow.

H J Waalkens 1, J Gerritsen 1, G H Koëter 1, F H Krouwels 1, W M van Aalderen 1, K Knol 1
PMCID: PMC463243  PMID: 1877037

Abstract

The effects of treatment with budesonide (200 micrograms twice daily) and terbutaline (500 micrograms four times daily) has been compared with the effects of placebo and terbutaline in 27 children with mild asthma, aged 7-14 years, in a double blind, randomised placebo controlled study over eight weeks. Bronchial responsiveness (PC20 histamine), lung function, the amplitude of diurnal variation in peak expiratory flow (PEF), and symptom scores were measured. Baseline FEV1 was over 70% predicted and PC20 histamine less than 8 mg/ml. Twelve children were treated with budesonide and terbutaline and 15 with placebo and terbutaline. After four and eight weeks of treatment the change in PC20 was significantly greater after budesonide and terbutaline than after terbutaline alone by 2.1 (95% CI 0.5-3.8) and 1.3 (95% CI 0.1-2.5) doubling doses respectively. Mean FEV1 did not change in either group. The change in afternoon and nocturnal PEF was significantly greater after budesonide and terbutaline than after terbutaline alone. The amplitude of diurnal variation in PEF did not change significantly in either group. Peak flow reversibility decreased in the budesonide group. There were no differences between treatments for cough and dyspnoea, but wheeze improved in the budesonide group. The children with mild asthma treated with budesonide and terbutaline showed improvement in bronchial responsiveness, afternoon and nocturnal PEF, and symptoms of wheeze and a fall in peak flow reversibility by comparison with those who received terbutaline alone.

Full text

PDF
499

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arnaud A., Vervloet D., Dugue P., Orehek J., Charpin J. Treatment of acute asthma: effect of intravenous corticosteroids and beta 2-adrenergic agonists. Lung. 1979;156(1):43–48. doi: 10.1007/BF02713990. [DOI] [PubMed] [Google Scholar]
  2. Barnes P. J. New concepts in the pathogenesis of bronchial hyperresponsiveness and asthma. J Allergy Clin Immunol. 1989 Jun;83(6):1013–1026. doi: 10.1016/0091-6749(89)90441-7. [DOI] [PubMed] [Google Scholar]
  3. Barnes P. J. Nocturnal asthma: mechanisms and treatment. Br Med J (Clin Res Ed) 1984 May 12;288(6428):1397–1398. doi: 10.1136/bmj.288.6428.1397. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Beasley R., Roche W. R., Roberts J. A., Holgate S. T. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis. 1989 Mar;139(3):806–817. doi: 10.1164/ajrccm/139.3.806. [DOI] [PubMed] [Google Scholar]
  5. Boushey H. A., Holtzman M. J., Sheller J. R., Nadel J. A. Bronchial hyperreactivity. Am Rev Respir Dis. 1980 Feb;121(2):389–413. doi: 10.1164/arrd.1980.121.2.389. [DOI] [PubMed] [Google Scholar]
  6. Cockcroft D. W., Killian D. N., Mellon J. J., Hargreave F. E. Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy. 1977 May;7(3):235–243. doi: 10.1111/j.1365-2222.1977.tb01448.x. [DOI] [PubMed] [Google Scholar]
  7. Cockcroft D. W., Ruffin R. E., Dolovich J., Hargreave F. E. Allergen-induced increase in non-allergic bronchial reactivity. Clin Allergy. 1977 Nov;7(6):503–513. doi: 10.1111/j.1365-2222.1977.tb01481.x. [DOI] [PubMed] [Google Scholar]
  8. Connolly C. K. Diurnal rhythms in airway obstruction. Br J Dis Chest. 1979 Oct;73(4):357–366. [PubMed] [Google Scholar]
  9. Dahl R., Johansson S. A. Effect on lung function of budesonide by inhalation, terbutaline s.c. and placebo given simultaneously or as single treatments. Eur J Respir Dis Suppl. 1982;122:132–137. [PubMed] [Google Scholar]
  10. Dahl R., Pedersen B., Hägglöf B. Nocturnal asthma: effect of treatment with oral sustained-release terbutaline, inhaled budesonide, and the two in combination. J Allergy Clin Immunol. 1989 Apr;83(4):811–815. doi: 10.1016/0091-6749(89)90019-5. [DOI] [PubMed] [Google Scholar]
  11. Dimeo M. J., Glenn M. G., Holtzman M. J., Sheller J. R., Nadel J. A., Boushey H. A. Threshold concentration of ozone causing an increase in bronchial reactivity in humans and adaptation with repeated exposures. Am Rev Respir Dis. 1981 Sep;124(3):245–248. doi: 10.1164/arrd.1981.124.3.245. [DOI] [PubMed] [Google Scholar]
  12. Ellul-Micallef R., Fenech F. F. Effect of intravenous prednisolone in asthmatics with diminished adrenergic responsiveness. Lancet. 1975 Dec 27;2(7948):1269–1271. doi: 10.1016/s0140-6736(75)90608-x. [DOI] [PubMed] [Google Scholar]
  13. Empey D. W., Laitinen L. A., Jacobs L., Gold W. M., Nadel J. A. Mechanisms of bronchial hyperreactivity in normal subjects after upper respiratory tract infection. Am Rev Respir Dis. 1976 Feb;113(2):131–139. doi: 10.1164/arrd.1976.113.2.131. [DOI] [PubMed] [Google Scholar]
  14. Gerritsen J., Koëter G. H., Postma D. S., Schouten J. P., Knol K. Prognosis of asthma from childhood to adulthood. Am Rev Respir Dis. 1989 Nov;140(5):1325–1330. doi: 10.1164/ajrccm/140.5.1325. [DOI] [PubMed] [Google Scholar]
  15. Hetzel M. R., Clark T. J. Comparison of normal and asthmatic circadian rhythms in peak expiratory flow rate. Thorax. 1980 Oct;35(10):732–738. doi: 10.1136/thx.35.10.732. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hetzel M. R., Clark T. J., Houston K. Physiological patterns in early morning asthma. Thorax. 1977 Aug;32(4):418–423. doi: 10.1136/thx.32.4.418. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Horn C. R., Clark T. J., Cochrane G. M. Inhaled therapy reduces morning dips in asthma. Lancet. 1984 May 26;1(8387):1143–1145. doi: 10.1016/s0140-6736(84)91392-8. [DOI] [PubMed] [Google Scholar]
  18. Jeffery P. K., Wardlaw A. J., Nelson F. C., Collins J. V., Kay A. B. Bronchial biopsies in asthma. An ultrastructural, quantitative study and correlation with hyperreactivity. Am Rev Respir Dis. 1989 Dec;140(6):1745–1753. doi: 10.1164/ajrccm/140.6.1745. [DOI] [PubMed] [Google Scholar]
  19. Kerrebijn K. F., van Essen-Zandvliet E. E., Neijens H. J. Effect of long-term treatment with inhaled corticosteroids and beta-agonists on the bronchial responsiveness in children with asthma. J Allergy Clin Immunol. 1987 Apr;79(4):653–659. doi: 10.1016/s0091-6749(87)80163-x. [DOI] [PubMed] [Google Scholar]
  20. Kraan J., Koëter G. H., vd Mark T. W., Sluiter H. J., de Vries K. Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: a comparison between budesonide and terbutaline. J Allergy Clin Immunol. 1985 Oct;76(4):628–636. doi: 10.1016/0091-6749(85)90786-9. [DOI] [PubMed] [Google Scholar]
  21. Laitinen L. A., Heino M., Laitinen A., Kava T., Haahtela T. Damage of the airway epithelium and bronchial reactivity in patients with asthma. Am Rev Respir Dis. 1985 Apr;131(4):599–606. doi: 10.1164/arrd.1985.131.4.599. [DOI] [PubMed] [Google Scholar]
  22. Lozewicz S., Wells C., Gomez E., Ferguson H., Richman P., Devalia J., Davies R. J. Morphological integrity of the bronchial epithelium in mild asthma. Thorax. 1990 Jan;45(1):12–15. doi: 10.1136/thx.45.1.12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Molema J., van Herwaarden C. L., Folgering H. T. Effects of long-term treatment with inhaled cromoglycate and budesonide on bronchial hyperresponsiveness in patients with allergic asthma. Eur Respir J. 1989 Apr;2(4):308–316. [PubMed] [Google Scholar]
  24. Peel E. T., Gibson G. J. Effects of long-term inhaled salbutamol therapy on the provocation of asthma by histamine. Am Rev Respir Dis. 1980 Jun;121(6):973–978. doi: 10.1164/arrd.1980.121.6.973. [DOI] [PubMed] [Google Scholar]
  25. Reinhardt D., Schuhmacher P., Fox A., Stemmann E. A., Wegner F. Comparison of the effects of theophylline, prednisolone and sleep withdrawal on airway obstruction and urinary cyclic AMP/cyclic GMP excretion of asthmatic children with and without nocturnal asthma. Int J Clin Pharmacol Ther Toxicol. 1980 Sep;18(9):399–404. [PubMed] [Google Scholar]
  26. Ryan G., Latimer K. M., Dolovich J., Hargreave F. E. Bronchial responsiveness to histamine: relationship to diurnal variation of peak flow rate, improvement after bronchodilator, and airway calibre. Thorax. 1982 Jun;37(6):423–429. doi: 10.1136/thx.37.6.423. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Sears M. R., Taylor D. R., Print C. G., Lake D. C., Li Q. Q., Flannery E. M., Yates D. M., Lucas M. K., Herbison G. P. Regular inhaled beta-agonist treatment in bronchial asthma. Lancet. 1990 Dec 8;336(8728):1391–1396. doi: 10.1016/0140-6736(90)93098-a. [DOI] [PubMed] [Google Scholar]
  28. Turner-Warwick M. Epidemiology of nocturnal asthma. Am J Med. 1988 Jul 29;85(1B):6–8. doi: 10.1016/0002-9343(88)90231-8. [DOI] [PubMed] [Google Scholar]
  29. van Aalderen W. M., Postma D. S., Koëter G. H., Knol K. The effect of reduction of maintenance treatment on circadian variation in peak expiratory flow rate values in asthmatic children. Acta Paediatr Scand. 1988 Mar;77(2):269–274. doi: 10.1111/j.1651-2227.1988.tb10641.x. [DOI] [PubMed] [Google Scholar]
  30. van Schayck C. P., Graafsma S. J., Visch M. B., Dompeling E., van Weel C., van Herwaarden C. L. Increased bronchial hyperresponsiveness after inhaling salbutamol during 1 year is not caused by subsensitization to salbutamol. J Allergy Clin Immunol. 1990 Nov;86(5):793–800. doi: 10.1016/s0091-6749(05)80185-x. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES